Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed
ID: 351204Type: Forecasted
Overview

Buyer

Food and Drug Administration (HHS-FDA)

Award Range

$0 - $200K

Eligible Applicants

Small Businesses

Funding Category

Food and Nutrition

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351204
Timeline
    Description

    The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity for the collection of long-term data on antimicrobial use in animals, with a focus on diverse sectors such as domestic livestock, poultry, and companion animals. The primary objectives of this initiative are to gather comprehensive antimicrobial use data and to contribute to the development of data collection frameworks that support antimicrobial stewardship in veterinary settings. This funding is crucial for advancing the FDA's initiatives and the National Action Plan's objectives to enhance understanding and management of antimicrobial use in animal agriculture. Interested small businesses can apply for a share of the estimated total program funding of $600,000, with an award ceiling of $200,000 per project, and are encouraged to contact Janelle Fundersburg at janelle.fundersburg@fda.hhs.gov or 301-798-2533 for further details.

    Point(s) of Contact
    Janelle Fundersburg Grants Management Specialist
    (301) 798-2533
    janelle.fundersburg@fda.hhs.gov
    Files
    No associated files provided.
    Similar Opportunities
    Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity titled "Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives." This cooperative agreement aims to enhance the capabilities of State animal food regulatory programs to fully implement the Animal Feed Regulatory Program Standards (AFRPS) and to develop standardized processes that promote mutual reliance between federal and state regulatory efforts. The initiative is crucial for establishing a nationally integrated animal food safety system, ensuring that state programs can effectively manage animal food safety regulations. Interested organizations must meet specific eligibility criteria, including the ability to enter into a 20.88 information disclosure agreement with the FDA, and the funding amount is set at $10.6 million, with approximately 30 awards expected. For further inquiries, applicants can contact Terrin Brown at terrin.brown@fda.hhs.gov or by phone at 240-402-7610.
    Minor Use Minor Species Development of Drugs (R01)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity for the development of drugs for minor uses in major species or for use in minor species through its Minor Use Minor Species Development of Drugs (R01) grant program. This initiative aims to support research projects that assist in the safety and effectiveness testing of new animal drugs designated for minor uses, with a focus on entities that have opened an Investigational New Animal Drug (INAD) file and received the necessary designations from the FDA's Office of Minor Use and Minor Species Animal Drug Development. The program is crucial for enhancing veterinary care options for less common animal species, ensuring that these drugs meet FDA approval standards. Interested applicants can apply for grants with a funding ceiling of $250,000, with an expected six awards available for the fiscal year 2025. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or by phone at (240) 402-7610.
    Vet-LIRN Capacity-Building Project and Equipment Grants (U18)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is offering the Vet-LIRN Capacity-Building Project and Equipment Grants (U18) to enhance the capabilities of veterinary diagnostic laboratories within the Vet-LIRN network. This funding opportunity aims to support projects focused on animal food safety, antimicrobial resistance, and surveillance efforts related to foodborne illnesses and emerging diseases, including COVID-19. The initiative is part of the FDA's commitment to improving food safety standards and aligns with the Food Safety Modernization Act, emphasizing the importance of federal involvement in bolstering food safety and containment capabilities. Interested applicants, including small businesses and various institutions, can apply for grants ranging from $225,000 to $2.5 million, with applications accepted annually until September 4, 2028. For further details, contact Kimberly Pendleton at kimberly.pendleton@fda.hhs.gov or visit the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-202.html.
    NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity for the NARMS Cooperative Agreement Program, aimed at strengthening antibiotic resistance surveillance in retail food specimens. This initiative seeks to enhance the National Antimicrobial Resistance Monitoring System (NARMS) by improving the detection of antibiotic resistance among bacteria in food commodities and expanding sampling efforts to new sites. The program is critical for public health as it addresses the growing threat of antibiotic resistance, ensuring better monitoring and response strategies. Interested applicants can apply for a total funding amount of up to $4.5 million, with an expected 30 awards available, and should contact Terrin Brown at terrin.brown@fda.hhs.gov or 240-402-7610 for further details.
    Animal Food Regulatory Program Alliance
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity titled "Animal Food Regulatory Program Alliance," aimed at enhancing the national food safety system through improved collaboration among federal and state agencies. The primary objective of this program is to support the development of a national integrated animal food safety system, which includes sharing best practices, conducting training programs, and advancing the Animal Food Regulatory Program Standards (AFRPS). This initiative is crucial for ensuring public health and consumer protection in the regulation of manufactured foods. Interested national associations or organizations that represent state animal food regulatory programs can apply for funding, with a total award amount of $600,000. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or call 240-402-7610. The fiscal year for this opportunity is 2025.
    Animal and Veterinary Innovation Centers (U18)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is inviting applications for the Animal and Veterinary Innovation Centers (U18) funding opportunity, aimed at establishing long-term partnerships to address critical research areas in veterinary medicine. This initiative focuses on driving research to prevent and control Highly Pathogenic Avian Influenza (HPAI), advancing regulatory science for intentional genomic alterations in animals, and developing veterinary products for underrepresented species and conditions. With an estimated total program funding of $3 million and awards of up to $1.25 million available, applications are due by August 5, 2024. Interested applicants, particularly higher education institutions serving minority populations, can find more information and submission guidelines at the provided link or contact Terrin Brown at terrin.brown@fda.hhs.gov.
    Minor Use Minor Species Development of Drugs (R01)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is offering a funding opportunity for research grants (R01) aimed at the development of new animal drugs for minor uses in major species or for minor species (MUMS). Eligible applicants include a variety of organizations such as higher education institutions, nonprofits, and for-profit entities engaged in veterinary drug development, with the goal of defraying costs associated with safety and effectiveness testing required for FDA approval of MUMS-designated drugs. This initiative underscores the FDA's commitment to enhancing veterinary medicine for less common uses and species, with funding available up to $250,000 per year for a maximum of three years. Interested parties must have an open Investigational New Animal Drug (INAD) file and a minor use or minor species designation, with application deadlines spanning from July 2024 to January 2027. For further details, applicants can contact Terrin Brown at terrin.brown@fda.hhs.gov.
    Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a grant opportunity titled "Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed." This initiative aims to establish and sustain Rapid Response Teams (RRTs) to enhance the national integrated food safety system by coordinating federal, state, and local emergency response efforts related to human and animal food safety. The program is critical for improving regulatory and surveillance capabilities, ensuring rapid identification and removal of contaminated food, and fostering continuous improvement in response strategies. Interested applicants, including state governments and other entities, can apply for funding ranging from $360,000 to $1,440,000, with an expected four awards to be made. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or by phone at 240-402-7610.
    Rapid Response Team (RRT) Cooperative Agreement
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity for the Rapid Response Team (RRT) Cooperative Agreement, aimed at enhancing the national integrated food safety system. This initiative seeks to unify and coordinate emergency response efforts related to human and animal food (HAF), focusing on strengthening connections among epidemiology, laboratory, and regulatory components, as well as improving state regulatory and surveillance programs. The total estimated funding for this program is $8,250,000, with approximately 25 awards expected, and interested small businesses can reach out to Janelle Fundersburg at 301-798-2533 or via email at janelle.fundersburg@fda.hhs.gov for further details. The synopsis is anticipated to be posted on September 1, 2022, with a closing date for applications on December 1, 2022, and awards expected to be made by July 1, 2023.
    Manufactured Foods Flexible Funding Model (MF-FFM)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity titled "Manufactured Foods Flexible Funding Model (MF-FFM)" aimed at advancing a nationally integrated food safety system. This cooperative agreement seeks to support initiatives related to Manufactured Food Regulatory Program Standards (MFRPS), dietary supplement safety, and state compliance and enforcement infrastructure, with a focus on enhancing food safety practices across jurisdictions. The program is critical for ensuring that state regulatory programs maintain high-quality standards and best practices in food safety. Interested applicants, which include state, local, territorial, and tribal agencies, as well as non-profit training entities collaborating with higher education institutions, can reach out to Gordana Zuber at gordana.zuber@fda.hhs.gov or by phone at 301-348-1747 for further details. The estimated project start date is July 1, 2023, with approximately 50 awards expected under this discretionary funding opportunity.